论文部分内容阅读
梯-5是一种较梯络龙疗效更好的抗矽肺新药,小鼠口服LD_(50)为1170mg/kg,对鼠伤寒沙门氏菌株TA_(97)、TA_(98)、TA_(100)和TA_(102)均未出现致突变作用,小鼠微核实验呈阴性结果。
The ladder-5 is a new anti-silicotic agent with better curative effect than tiger-dragone. The oral LD_ (50) of mice is 1170mg / kg. The effects of TA_ (97), TA_ (98), TA_ (100) TA_ (102) did not mutagenic effect, the mouse micronucleus test was negative.